An ACAT inhibitor regulates SARS-CoV-2 replication and antiviral T cell activity
Schmidt NM., Wing PAC., Peters R., Brown R., Wang H., Swadling L., Newman J., Thakur N., Shionoya K., Morgan SB., Hinks TSC., Watashi K., Bailey D., Hansen SB., Maini MK., McKeating JA.